(Q58190241)

5

object named as

U. de Faire

0 references

author name string

A. Cederholm

2

0 references

K. Jensen‐Urstad

3

0 references

G.‐Z. Fei

4

0 references

J. Frostegård

Scandinavian Journal of Rheumatology

6

0 references

publication date

January 2008

0 references

published in

0 references

volume

37

0 references

issue

5

0 references

page(s)

352-359

0 references

cites work

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

SLE, atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Systemic nature of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Cellular adhesion molecules and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Measurement of systemic lupus erythematosus activity in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

A methodological study of arterial wall function using ultrasound technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

The A-1087IL-10 allele is associated with cardiovascular disease in SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Impaired endothelial function in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Circulating cell adhesion molecules and death in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

TNF signaling in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Effect of Sulfhydryl and non-Sulfhydryl Angiotensin-Converting Enzyme Inhibitors on Endothelial Function in Essential Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514

Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740802007514